Coronavirus Vaccine update: In India, Pfizer’s COVID-19 vaccine might cost roughly Rs 730 per dose. On the off chance that Pfizer’s COVID-19 hit is made accessible at under $10 a portion in India, the cost would be practically a large portion of that of the created markets like the US, the UK, and the EU
A solitary portion of Pfizer’s COVID-19 immunization might be estimated under $10 (about Rs 730) in India, which could be the most minimal cost for the mRNA-based hit internationally.
“It is a solitary digit cost for each portion. This is a not-revenue driven cost for the public authority’s vaccination program,” Business Standard referring to sources as saying. The two-shot antibody has been made by the American pharma goliath and its German accomplice BioNTech.
Also Read – Tea Recipe To Lower The mucous Excess
In the event that the antibody goes under $10 in the country, the cost would be practically a large portion of that of in created markets like the United States, United Kingdom, and European Union, the report said.
The Pfizer COVID antibody is estimated in the US for $19.5 (Rs 1,423) a portion. In the UK, it costs around $21 (Rs 1,532). In the EU, prior the cost was around $18.9 a portion yet value exchanges are in progress at a greater expense of $23.2 (Rs 1,693) a portion, according to the report.